These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31337885)

  • 1. Outcomes of patient self-referral for the diagnosis of several rare inherited kidney diseases.
    Bleyer AJ; Kidd K; Robins V; Martin L; Taylor A; Santi A; Tsoumas G; Hunt A; Swain E; Abbas M; Akinbola E; Vidya S; Moossavi S; Bleyer AJ; Živná M; Hartmannová H; Hodaňová K; Vyleťal P; Votruba M; Harden M; Blumenstiel B; Greka A; Kmoch S
    Genet Med; 2020 Jan; 22(1):142-149. PubMed ID: 31337885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease.
    Gast C; Marinaki A; Arenas-Hernandez M; Campbell S; Seaby EG; Pengelly RJ; Gale DP; Connor TM; Bunyan DJ; Hodaňová K; Živná M; Kmoch S; Ennis S; Venkat-Raman G
    BMC Nephrol; 2018 Oct; 19(1):301. PubMed ID: 30376835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant tubulointerstitial kidney disease (ADTKD) in Ireland.
    Cormican S; Connaughton DM; Kennedy C; Murray S; Živná M; Kmoch S; Fennelly NK; O'Kelly P; Benson KA; Conlon ET; Cavalleri G; Foley C; Doyle B; Dorman A; Little MA; Lavin P; Kidd K; Bleyer AJ; Conlon PJ
    Ren Fail; 2019 Nov; 41(1):832-841. PubMed ID: 31509055
    [No Abstract]   [Full Text] [Related]  

  • 4. Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.
    Ayasreh N; Bullich G; Miquel R; Furlano M; Ruiz P; Lorente L; Valero O; García-González MA; Arhda N; Garin I; Martínez V; Pérez-Gómez V; Fulladosa X; Arroyo D; Martínez-Vea A; Espinosa M; Ballarín J; Ars E; Torra R
    Am J Kidney Dis; 2018 Sep; 72(3):411-418. PubMed ID: 29784615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in patients with autosomal dominant tubulointerstitial kidney disease
.
    Bleyer AJ; Kidd K; Johnson E; Robins V; Martin L; Taylor A; Pinder AJ; Bowline I; Frankova V; Živná M; Taylor KB; Kim N; Baek JJ; Hartmannová H; Hodaňová K; Vyleťal P; Votruba M; Kmoch S
    Clin Nephrol; 2019 Dec; 92(6):302-311. PubMed ID: 31587753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpectedly high prevalence of rare genetic disorders in kidney transplant recipients with an unknown causal nephropathy.
    Quaglia M; Musetti C; Ghiggeri GM; Fogazzi GB; Settanni F; Boldorini RL; Lazzarich E; Airoldi A; Izzo C; Giordano M; Stratta P
    Clin Transplant; 2014 Sep; 28(9):995-1003. PubMed ID: 24961278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of kidney biopsy in autosomal dominant tubulointerstitial kidney disease-UMOD: is kidney biopsy truly nonspecific?
    Onoe T; Hara S; Yamada K; Zoshima T; Mizushima I; Ito K; Mori T; Daimon S; Muramoto H; Shimizu M; Iguchi A; Kuma A; Ubara Y; Mitobe M; Tsuruta H; Kishimoto N; Imura J; Konoshita T; Kawano M
    BMC Nephrol; 2021 Jan; 22(1):1. PubMed ID: 33397327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutation: A Two-Case Report and Literature Review.
    Liang D; Liang S; Zhang M; Gao E; Zhang Z; Jin Y; Xu F; Zeng C
    Nephron; 2019; 143(4):282-287. PubMed ID: 31422399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of undiagnosed diseases network applicants: implications for referring providers.
    Walley NM; Pena LDM; Hooper SR; Cope H; Jiang YH; McConkie-Rosell A; Sanders C; Schoch K; Spillmann RC; Strong K; McCray AT; Mazur P; Esteves C; LeBlanc K; ; Wise AL; Shashi V
    BMC Health Serv Res; 2018 Aug; 18(1):652. PubMed ID: 30134969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare inherited kidney diseases: challenges, opportunities, and perspectives.
    Devuyst O; Knoers NV; Remuzzi G; Schaefer F;
    Lancet; 2014 May; 383(9931):1844-59. PubMed ID: 24856029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel UMOD mutation (c.163G>A) in a Brazilian family with autosomal dominant tubulointerstitial kidney disease.
    Lopes LB; Abreu CC; Souza CF; Guimaraes LER; Silva AA; Aguiar-Alves F; Kidd KO; Kmoch S; Bleyer AJ; Almeida JR
    Braz J Med Biol Res; 2018 Mar; 51(3):e6560. PubMed ID: 29513881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare diseases, common barriers: disparities in pediatric clinical genetics outcomes.
    Wojcik MH; Bresnahan M; Del Rosario MC; Ojeda MM; Kritzer A; Fraiman YS
    Pediatr Res; 2023 Jan; 93(1):110-117. PubMed ID: 35963884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine Learning of Patient Characteristics to Predict Admission Outcomes in the Undiagnosed Diseases Network.
    Amiri H; Kohane IS;
    JAMA Netw Open; 2021 Feb; 4(2):e2036220. PubMed ID: 33630084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new missense mutation in UMOD gene leads to severely reduced serum uromodulin concentrations - A tool for the diagnosis of uromodulin-associated kidney disease.
    Satanovskij R; Bader A; Block M; Herbst V; Schlumberger W; Haack T; Nockher WA; Heemann U; Renders L; Schmaderer C; Angermann S; Wen M; Meitinger T; Scherberich J; Steubl D
    Clin Biochem; 2017 Feb; 50(3):155-158. PubMed ID: 27729211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive Immunohistochemical Diagnosis and Novel
    Živná M; Kidd K; Přistoupilová A; Barešová V; DeFelice M; Blumenstiel B; Harden M; Conlon P; Lavin P; Connaughton DM; Hartmannová H; Hodaňová K; Stránecký V; Vrbacká A; Vyleťal P; Živný J; Votruba M; Sovová J; Hůlková H; Robins V; Perry R; Wenzel A; Beck BB; Seeman T; Viklický O; Rajnochová-Bloudíčková S; Papagregoriou G; Deltas CC; Alper SL; Greka A; Bleyer AJ; Kmoch S
    J Am Soc Nephrol; 2018 Sep; 29(9):2418-2431. PubMed ID: 29967284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Integrated Kidney Care eConsult Practice Model: Results from the iKinect Project.
    Ong SW; Kaushal A; Pariser P; Chan CT
    Am J Nephrol; 2019; 50(4):262-271. PubMed ID: 31473734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of Next-Generation Sequencing in Rare Renal Diseases].
    Cai ZY; Zhao JR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):484-490. PubMed ID: 35791948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uromodulin: from physiology to rare and complex kidney disorders.
    Devuyst O; Olinger E; Rampoldi L
    Nat Rev Nephrol; 2017 Sep; 13(9):525-544. PubMed ID: 28781372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Hereditary Colorectal Cancer Referral Patterns to a Tertiary Care Center: A Novel Approach Using Geographic Information System Mapping.
    Ford MM; Camp JV; Geiger TM; Hopkins MB; Muldoon RL; Prestwich A; LaNeve DC; Hawkins AT
    Dis Colon Rectum; 2019 Jul; 62(7):840-848. PubMed ID: 31188185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare disease centers for periodic paralysis: China versus the United States and United Kingdom.
    Ke Q; Qi M; Wu W; Luo B; Hanna M; Herr B; Griggs RC;
    Muscle Nerve; 2014 Feb; 49(2):171-4. PubMed ID: 23893386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.